Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-042351
Filing Date
2014-06-18
Accepted
2014-06-18 16:39:43
Documents
1
Period of Report
2014-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3344
  Complete submission text file 0001209191-14-042351.txt   4763
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL STREET, SUITE 110 WATERTOWN MA 02472
Business Address
Lubner David Charles (Reporting) CIK: 0001572000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 14928449